Skip to main content

Table 3 Regional differences in fulfilment of classification criteria

From: The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study

  Number of patients included Patients fulfilling Amor criteria, n (%) Patients fulfilling mAmor criteria, n (%) Patients fulfilling ESSG criteria, n (%) Patients fulfilling mESSG criteria, n (%) Total patients fulfilling ASAS SpA criteria, n (%) Patients fulfilling ASAS axSpAcriteria, n (%) Patients fulfilling, ASAS pSpA criteria, n (%) Patients fulfilling CASPAR criteria, n (%)
Western Europe 1507 1242 (82.4%) 1333 (88.5%) 1335 (88.6%) 1433 (95.1%) 1305 (86.6%) 1149 (76.2%) 156 (10.4%) 388 (25.7%)
Central Europe 438 342 (78.1%) 364 (83.1%) 402 (91.8%) 419 (95.7%) 391 (89.3%) 368 (84.0%) 23 (5.3%) 32 (7.3%)
North America 239 203 (84.9%) 205 (85.8%) 219 (91.6%) 219 (91.6%) 176 (73.6%) 122 (51.0%) 54 (22.6%) 120 (50.2%)
Latin America 348 290 (83.3%) 307 (88.2%) 314 (90.2%) 326 (93.7%) 280 (80.5%) 239 (68.7%) 41 (11.8%) 93 (26.7%)
North Africa 337 300 (89.0%) 310 (92.0%) 316 (93.8%) 324 (96.1%) 308 (91.4%) 260 (77.2%) 48 (14.2%) 94 (27.9%)
Asia 1073 905 (84.3%) 935 (87.1%) 899 (83.8%) 931 (86.8%) 910 (84.8%) 817 (76.1%) 93 (8.7%) 125 (11.6%)
  1. Abbreviations: ASAS Assessment of SpondyloArthritis international Society, axSpA Axial spondyloarthritis, CASPAR ClASsification criteria for Psoriatic Arthritis, ESSG European Spondyloarthropathy Study Group, mAmor Modified Amor, mESSG Modified European Spondyloarthropathy Study Group, pSpA Peripheral spondyloarthritis, SpA Spondyloarthritis
  2. Percentages relate to number of patients of that specific region